A detailed history of Rafferty Asset Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 246,999 shares of HUMA stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246,999
Previous 104,296 136.82%
Holding current value
$1.2 Million
Previous $500,000 168.6%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.11 - $9.46 $729,212 - $1.35 Million
142,703 Added 136.82%
246,999 $1.34 Million
Q2 2024

Aug 13, 2024

BUY
$2.87 - $9.1 $299,329 - $949,093
104,296 New
104,296 $500,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $499M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.